BUSINESSThe Dales Report
MariMed details record quarter and wholesale-first New York plan
MariMed executives told The Dales Report that third-quarter revenue reached a record $44.2 million, adjusted EBITDA rose to $4.7 million and branded products reached 721 stores. The company also outlined a wholesale and licensing strategy for New York and discussed debt, a reverse split and possible merger partners, giving Oklahoma operators a direct benchmark for brand expansion and consolidation planning.
Published Nov 16, 2026
Read the full article at The Dales Report#national#capital#market-data#licensing#public-companies
Read the original source
Leafy summaries provide industry context. Confirm details with The Dales Report.